Contact
Please use this form to send email to PR contact of this press release:
OKYO Pharma Announces Promising Categorical Data from OK-101 Phase 2 Trial in Dry Eye Disease
TO:
Please use this form to send email to PR contact of this press release:
OKYO Pharma Announces Promising Categorical Data from OK-101 Phase 2 Trial in Dry Eye Disease
TO: